The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial

OBJECTIVES: To evaluate the immunogenicity of an extended interval regimen of BNT162b2 among healthy school-age children. METHODS: A randomized-control trial conducted among healthy Thai children aged 5-11 years. Participants received two doses of BNT162b2 with an 8-week (extended dosing) vs 3-week...

Descripción completa

Detalles Bibliográficos
Autores principales: Chantasrisawad, Napaporn, Techasaensiri, Chonnamet, Kosalaraksa, Pope, Phongsamart, Wanatpreeya, Tangsathapornpong, Auchara, Jaru-Ampornpan, Peera, Sophonphan, Jiratchaya, Suntarattiwong, Piyarat, Puthanakit, Thanyawee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011807/
https://www.ncbi.nlm.nih.gov/pubmed/36841501
http://dx.doi.org/10.1016/j.ijid.2023.02.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011807/
https://www.ncbi.nlm.nih.gov/pubmed/36841501
http://dx.doi.org/10.1016/j.ijid.2023.02.017

Ejemplares similares